HealthTrackRx Opens $45.5 Million Facility to Double Infectious Disease Testing Capacity
The new Louisville campus aims to deliver next-morning molecular diagnostic results to 5 million patient samples annually nationwide.
The new Louisville campus aims to deliver next-morning molecular diagnostic results to 5 million patient samples annually nationwide.
Greer Massey, PhD, chief scientific officer at Molecular Designs, shares insights on how labs are affected by the rule’s reversal and how they can prepare for future regulatory changes.
The Fast PCR Mini Respiratory Panel simultaneously detects Flu A, Flu B, RSV, and SARS-CoV-2 from nasal swab specimens.
The tool provides real-time support for experiment troubleshooting, protocol optimization, and data analysis within the existing workflow.
SeptiCyte RAPID demonstrated superior performance compared to procalcitonin and C-reactive protein in detecting sepsis among critically ill patients with hospital-acquired infections.